MedPath

江西和盈药业有限公司

Ownership
-
Established
2003-05-13
Employees
-
Market Cap
-
Website
www.heyingyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

NMPA:24

Drug Approvals

Bupivacaine Hydrochloride Injection

Product Name
盐酸布比卡因注射液
Approval Number
国药准字H20249767
Approval Date
Dec 25, 2024
NMPA

Bupivacaine Hydrochloride Injection

Product Name
盐酸布比卡因注射液
Approval Number
国药准字H20249759
Approval Date
Dec 17, 2024
NMPA

Pentoxifylline Injection

Product Name
己酮可可碱注射液
Approval Number
国药准字H20243991
Approval Date
Jul 30, 2024
NMPA

Compound Balloonflower and Ephedrine Syrup(Ⅱ)

Product Name
复方桔梗麻黄碱糖浆
Approval Number
国药准字H20059295
Approval Date
Jan 11, 2024
NMPA

Inosine Oral Solution

Product Name
肌苷口服液
Approval Number
国药准字H20058568
Approval Date
Jan 11, 2024
NMPA

人参首乌精

Approval Number
国药准字Z20055287
Approval Date
Jan 8, 2024
NMPA

杞菊地黄口服液

Approval Number
国药准字Z20055292
Approval Date
Dec 20, 2023
NMPA

养血当归糖浆

Approval Number
国药准字Z20054837
Approval Date
Jul 11, 2022
NMPA

养血当归糖浆

Approval Number
国药准字Z20055295
Approval Date
May 12, 2022
NMPA

半夏糖浆

Approval Number
国药准字Z20055285
Approval Date
Sep 24, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.